Medropharm

Medropharm is a Swiss pharmaceutical company specializing in the research, development, and production of cannabinoid-based products and active pharmaceutical ingredients (APIs). The company focuses on high-quality, GMP-compliant extraction and purification of compounds like cannabidiol (CBD) and tetrahydrocannabinol (THC) for medical applications. Medropharm provides a range of services including contract manufacturing and the supply of standardized cannabis extracts to the global healthcare market. Their portfolio supports therapeutic areas such as pain management, neurology, and inflammatory diseases. The company is recognized for its commitment to pharmaceutical-grade purity and rigorous quality control standards.